Hippocampal synaptic dysfunction driven by toxic amyloid-β oligomers (AβO) is an early event in the progression of neurodegeneration and cognitive decline in Alzheimer's disease (AD). Non-invasive photobiomodulation therapy (PBM) is a promising intervention that has been shown to reduce amyloid and tau pathology, improve synaptic function, and preserve hippocampal neurogenesis in animal models of AD. Nano-pulsed laser therapy (NPLT) is a type of PBM therapy using pulsed 808 nm near-infrared laser light and optoacoustically generated ultrasound waves to stimulate deeper brain structures than would be accessible by traditional PBM therapy. We hypothesize that NPLT can effectively modulate hippocampal neurogenesis to induce resilience against AD.
Objective
To assess resilience of hippocampal neurons derived from NPLT-treated neural stem cells (NSC) against AβO toxicity.
Methods
We use NPLT to stimulate adult hippocampal neural stem cells (NSC) then induce neuronal differentiation in vitro and assess the mature neurons for AβO binding capacity and mitochondrial toxicity, and gene expression changes after NPLT.
Results
We found that neurons differentiated from NPLT-treated NSC are resilient against AβO binding and mitochondrial toxicity, and show increased expression of genes associated with autophagy and proteostasis.
Conclusions
Our findings support the hypothesis that NPLT modulation of hippocampal neurogenesis can be an effective non-invasive approach to induce resilience against AD toxic oligomers.
van DyckCHSwansonCJAisenP, et al.Lecanemab in early Alzheimer’s disease. N Engl J Med2023; 388: 9–21.
3.
SimsJRZimmerJAEvansCD, et al.Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA2023; 330: 512–527.
4.
VillemagneVLBurnhamSBourgeatP, et al.Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol2013; 12: 357–367.
5.
BatemanRJXiongCBenzingerTLS, et al.Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med2012; 367: 795–804.
6.
Colucci-D’AmatoLBonavitaVPorzioU. The end of the central dogma of neurobiology: stem cells and neurogenesis in adult CNS. Neurol Sci2006; 27: 266–270.
7.
Ramon y CajalS. Degeneration and regeneration of the nervous system. Oxford, UK: Clarendon Press, 1928.
8.
AltmanJ. Are new neurons formed in the brains of adult mammals?Science1962; 135: 1127–1128.
9.
AltmanJDasGD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol1965; 124: 319–335.
10.
KaplanMSHindsJW. Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science1977; 197: 1092–1094.
11.
ReynoldsBAWeissS. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science1992; 255: 1707–1710.
12.
PalmerTDTakahashiJGageFH. The adult rat hippocampus contains primordial neural stem cells. Mol Cell Neurosci1997; 8: 389–404.
13.
WangCLOhkuboRMuWC, et al.The mitochondrial unfolded protein response regulates hippocampal neural stem cell aging. Cell Metab2023; 35: 996–1008.e7.
14.
HarrisLRigoPStiehlT, et al.Coordinated changes in cellular behavior ensure the lifelong maintenance of the hippocampal stem cell population. Cell Stem Cell2021; 28: 863–876.e6.
15.
AudesseAJDhakalSHassellLA, et al.FOXO3 Directly regulates an autophagy network to functionally regulate proteostasis in adult neural stem cells. PLoS Genet2019; 15: e1008097.
16.
BeckervordersandforthREbertBSchäffnerI, et al.Role of mitochondrial metabolism in the control of early lineage progression and aging phenotypes in adult hippocampal neurogenesis. Neuron2017; 93: 560–573.e6.
17.
BoldriniMFulmoreCATarttAN, et al.Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell2018; 22: 589–599.
18.
Moreno-JiménezEPFlor-GarcíaMTerreros-RoncalJ, et al.Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat Med2019; 25: 554–560.
19.
BrileyDGhirardiVWoltjerR, et al.Preserved neurogenesis in non-demented individuals with AD neuropathology. Sci Rep2016; 6: 27812.
20.
HamblinMR. Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochem Photobiol2018; 94: 199–212.
21.
PchelinPShkarupaDSmetaninaN, et al.Red light photobiomodulation rescues murine brain mitochondrial respiration after acute hypobaric hypoxia. J Photochem Photobiol B2023; 239: 112643.
22.
Wong-RileyMTTLiangHLEellsJT, et al.Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J Biol Chem2005; 280: 4761–4771.
23.
StepanovYVGolovynskaIZhangR, et al.Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: mechanisms of light therapy for Alzheimer’s disease. Alzheimers Res Ther2022; 14: 84.
24.
WuXShenQChangH, et al.Promoted CD4+ T cell-derived IFN-γ/IL-10 by photobiomodulation therapy modulates neurogenesis to ameliorate cognitive deficits in APP/PS1 and 3xTg-AD mice. J Neuroinflammation2022; 19: 253.
25.
Ahamed BashaAMathangiDCShyamalaR. Effect of LED photobiomodulation on fluorescent light induced changes in cellular ATPases and cytochrome c oxidase activity in Wistar rat. Lasers Med Sci2016; 31: 1803–1809.
26.
SalehpourFKhademiMHamblinMR. Photobiomodulation therapy for dementia: a systematic review of pre-clinical and clinical studies. J Alzheimers Dis2021; 83: 1431–1452.
27.
BermanMHHalperJPNicholsTW, et al.Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memory and cognition. J Neurol Neurosci2017; 8: 176.
28.
HuangJHNizamutdinovDQiX, et al.Transcranial near infrared light stimulations improve cognition in patients with dementia. Aging Dis2021; 12: 954–963.
29.
SchifferFJohnstonALRavichandranC, et al.Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct2009; 5: 46.
30.
LeeTLChanDYChanDT, et al.Transcranial photobiomodulation improves cognitive function, post-concussion, and PTSD symptoms in mild traumatic brain injury. J Neurotrauma2025; 42: 1695–1707.
31.
WuQXuanWAndoT, et al.Low-level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths. Lasers Surg Med2012; 44: 218–226.
32.
XuanWAgrawalTHuangL, et al.Low-level laser therapy for traumatic brain injury in mice increases brain derived neurotrophic factor (BDNF) and synaptogenesis. J Biophotonics2015; 8: 502–511.
33.
OronAOronUChenJ, et al.Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke2006; 37: 2620–2624.
34.
YunYCJangDYoonSB, et al.Laser acupuncture exerts neuroprotective effects via regulation of Creb, Bdnf, Bcl-2, and Bax gene expressions in the hippocampus. Evid Based Complement Alternat Med2017; 2017: 7181637.
35.
JohnsonKJJohnsonKGrantA, et al.Photobiomodulation therapy increases neural stem cell pool in aged 3xTg-AD mice. PLoS One2025; 20: e0321668.
36.
KaruTIPyatibratLVKolyakovSF, et al.Absorption measurements of a cell monolayer relevant to phototherapy: reduction of cytochrome c oxidase under near IR radiation. J Photochem Photobiol B2005; 81: 98–106.
37.
WangEBKaurRFierroM, et al.Safety and penetration of light into the brain. In: HamblinMRHuangY (eds) Photobiomodulation in the brain. London, UK: Elsevier Inc., 2019, pp.49–66.
38.
GiacciMKWheelerLLovettS, et al.Differential effects of 670 and 830 nm red near infrared irradiation therapy: a comparative study of optic nerve injury, retinal degeneration, traumatic brain and spinal cord injury. PLoS One2014; 9: e104565.
39.
HamblinMRHuangYYSharmaSK, et al.Biphasic dose response in low level light therapy - an update. Dose Response2011; 9: 602–618.
40.
HashmiJTHuangYYSharmaSK, et al.Effect of pulsing in low-level light therapy. Lasers Surg Med2010; 42: 450–466.
41.
TangLJiangHSunM, et al.Pulsed transcranial photobiomodulation generates distinct beneficial neurocognitive effects compared with continuous wave transcranial light. Lasers Med Sci2023; 38: 203.
42.
EsenalievROPetrovIYPetrovY, et al.Nano-pulsed laser therapy is neuroprotective in a rat model of blast-induced neurotrauma. J Neurotrauma2018; 1522: 1510–1522.
43.
MocciaroEGrantAEsenalievRO, et al.Non-invasive transcranial nano-pulsed laser therapy ameliorates cognitive function and prevents aberrant migration of neural progenitor cells in the hippocampus of rats subjected to traumatic brain injury. J Neurotrauma2020; 1123: 1108–1123.
44.
PetrovIYMicciM-AProughDS, et al.Optoacoustic theranostics. Proc. SPIE 10494, Photons Plus Ultrasound: Imaging and Sensing 2018, 104941F. 28 March 2018.
45.
MarcattiMFracassiAMontalbanoM, et al.Aβ / tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer ‘ s disease. Cell Mol Life Sci2022; 79: 222.
46.
MicciMAKrishnanBBishopE, et al.Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes. Mol Neurodegener2019; 14: 25.
47.
ReeseLCZhangWRDineleyKT, et al.Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Aging Cell2008; 7: 824–835.
48.
ComerotaMMKrishnanBTaglialatelaG. Near infrared light decreases synaptic vulnerability to amyloid beta oligomers. Sci Rep2017; 7: 15012.
49.
FracassiAMarcattiMZolochevskaO, et al.Oxidative damage and antioxidant response in frontal cortex of demented and nondemented individuals with Alzheimer’s neuropathology. J Neurosci2021; 41: 538–554.
50.
MarinoCKrishnanBCappelloF, et al.Hsp60 protects against amyloid β oligomer synaptic toxicity via modification of toxic oligomer conformation. ACS Chem Neurosci2019; 10: 2858–2867.
51.
SchaeferPMVon EinemBWaltherP, et al.Metabolic characterization of intact cells reveals intracellular amyloid beta but not its precursor protein to reduce mitochondrial respiration. PLoS One2016; 11: e0168157.
52.
CasleyCSCanevariLLandJM, et al.β-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem2002; 80: 91–100.
53.
CalkinsMJReddyPH. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer ‘ s disease neurons. Biochem Biophys Acta2011; 1812: 507–513.
54.
WangXTianFSoniSS, et al.Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser. Sci Rep2016; 6: 30540.
55.
ZhouRYazdiASMenuP. A role for mitochondria in NLRP3 inflammasome activation. Nature2011; 469: 221–225.
56.
ZhongZUmemuraASanchez-LopezE, et al.NF-κB restricts inflammasome activation via elimination of damaged mitochondria. Cell2016; 164: 896–910.
57.
GeSXJungDJungD, et al.ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics2020; 36: 2628–2629.
KnothRSingecIDitterM, et al.Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100 years. PLoS One2010; 5: e8809.
60.
IbrayevaABayMPuE, et al.Early stem cell aging in the mature brain. Cell Stem Cell2021; 28: 955–966.e7.
61.
KalamakisGBrüneDRavichandranS, et al.Quiescence modulates stem cell maintenance and regenerative capacity in the aging brain. Cell2019; 176: 1407–1419.e14.
62.
HamiltonLKAumontAJulienC, et al.Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer’s disease. Eur J Neurosci2010; 32: 905–920.
63.
YenkoyanKMargaryanTMatinyanS, et al.Effects of β-amyloid (1-42) administration on the main neurogenic niches of the adult brain: amyloid-induced neurodegeneration influences neurogenesis. Int J Mol Sci2022; 23: 15444.
64.
KomlevaYKLopatinaOLGorinaYV, et al.Early changes in hyppocampal neurogenesis induced by soluble Aβ1–42 oligomers. Biochem Mosc Suppl B Biomed Chem2018; 12: 330–338.
65.
JinKGalvanVXieL, et al.Enhanced neurogenesis in Alzheimer’s disease transgenic (PDGF-APP Sw,Ind) mice. Proc Natl Acad Sci U S A2004; 101: 13363–13367.
66.
PerryEKJohnsonMEkonomouA, et al.Neurogenic abnormalities in Alzheimer ‘ s disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis2012; 47: 155–162.
67.
MeyerKFeldmanHMLuT, et al.REST And neural gene network dysregulation in iPSC models of Alzheimer’s disease. Cell Rep2019; 26: 1112–1127.e9.
68.
SahayAScobieKNHillAS, et al.Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature2011; 472: 466–470.
69.
WalgraveHBalusuSSnoeckS, et al.Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer’s disease. Cell Stem Cell2021; 28: 1805–1821.e8.
70.
ToniNGallopinTRichetinK, et al.Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer’s disease. Brain2015; 138: 440–455.
71.
EvansATerstegeDJScottGA, et al.Neurogenesis mediated plasticity is associated with reduced neuronal activity in CA1 during context fear memory retrieval. Sci Rep2022; 12: 7016.
72.
GeSYangCHsuK, et al.A critical period for enhanced synaptic plasticity in newly generated neurons of the adult brain. Neuron2007; 54: 105–110.
73.
Schmidt-HieberCJonesPBischofbergerJ. Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature2004; 429: 184–187.
74.
EbenezerPJWeidnerAMLeVineHIII, et al.Neuron specific toxicity of oligomeric beta amyloid: implications for JUN-kinase and oxidative stress. J Alzheimers Dis2012; 22: 839–848.
PuzzoDPiacentiniRFáM, et al.LTP And memory impairment caused by extracellular aβ and tau oligomers is APP-dependent. Elife2017; 6: e26991.
77.
DineleyKTKayedRNeugebauerV, et al.Amyloid-β oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J Neurosci Res2010; 88: 2923–2932.
KadamangudiSMarcattiMZhangWR, et al.Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses. Acta Neuropathol2024; 149: 2.
80.
ComerotaMMTumurbaatarBKrishnanB, et al.Near infrared light treatment reduces synaptic levels of toxic tau oligomers in two transgenic mouse models of human tauopathies. Mol Neurobiol2019; 56: 3341–3355.
81.
MohrinMWidjajaALiuY, et al.The mitochondrial unfolded protein response is activated upon hematopoietic stem cell exit from quiescence. Aging Cell2018; 17: e12756.
82.
YinJReimanEMBeachTG, et al.Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology2020; 94: E2404–E2411.
83.
ZhaoJIkezuTCLuW, et al.APOE Deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids. Stem Cell Res Ther2023; 14: 214.
84.
ZhaoJFuYYamazakiY, et al.APOE4 Exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids. Nat Commun2020; 11: 5540.
85.
Meyer-AcostaKKDiaz-GuerraEVarmaP, et al.APOE4 Impacts cortical neurodevelopment and alters network formation in human brain organoids. Stem Cell Rep2025; 20: 102537.
86.
LinYTSeoJGaoF, et al.APOE4 Causes widespread molecular and cellular alterations associated with Alzheimer’s disease phenotypes in human iPSC-derived brain cell types. Neuron2018; 98: 1141–1154.e7.
87.
TumurbaatarBFracassiAScadutoP, et al.Preserved autophagy in cognitively intact non-demented individuals with Alzheimer ‘ s neuropathology. Alzheimers Dement2023; 19: 5355–5370.
88.
VonkWIMRainboltTKDolanPT, et al.Differentiation drives widespread rewiring of the neural stem cell chaperone network. Mol Cell2020; 78: 329–345.e9.
89.
AlbertiGPaladinoLVitaleAM, et al.Functions and therapeutic potential of extracellular hsp60, hsp70, and hsp90 in neuroinflammatory disorders. Appl Sci2021; 11: 736.
90.
SchieberMChandelNS. ROS Function in redox signaling and oxidative stress. CURBIO2014; 24: R453–R462.
91.
Averill-BatesD. Reactive oxygen species and cell signaling. Review. Biochim Biophys Acta Mol Cell Res2024; 1871: 119573.
92.
Redza-DutordoirMDAA-B. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta Mol Cell Res2016; 1863: 2977–2992.
93.
ZhangZShenQWuX, et al.Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces aβ levels in Alzheimer’s disease models. Aging Cell2020; 19: e13054.
94.
DongWLiuSLiS, et al.Cell reprogramming therapy for Parkinson’s disease. Neural Regen Res2024; 19: 2444–2455.
95.
MorizaneA. Cell therapy for Parkinson's disease with induced pluripotent stem cells. Inflamm Regen2023; 43: 16.
96.
Stoddard-BennettTPeraR. Stem cell therapy for Parkinson’s disease: safety and modeling. Neural Regen Res2020; 15: 36–40.
97.
DoiDMagotaniHKikuchiT, et al.Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease. Nat Commun2020; 11: 3369.
98.
CummingsJ. Lessons learned from Alzheimer disease: clinical trials with negative outcomes. Clin Transl Sci2018; 11: 147–152.
99.
Budd HaeberleinSAisenPSBarkhofF, et al.Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease. J Prev Alzheimers Dis2022; 9: 197–210.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
